BX Swiss TOP 30 CHF
|
1 324,81
|
9,24
|
0,70 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
| 06.02.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 05.02.24 | Roche Sell | Deutsche Bank AG | |
| 05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
| 05.02.24 | Roche Neutral | UBS AG | |
| 02.02.24 | ABB Sector Perform | RBC Capital Markets | |
| 02.02.24 | Roche Kaufen | DZ BANK | |
| 02.02.24 | Roche Equal Weight | Barclays Capital | |
| 02.02.24 | Roche Sell | Deutsche Bank AG | |
| 02.02.24 | ABB Hold | Deutsche Bank AG | |
| 02.02.24 | Novartis Buy | Deutsche Bank AG | |
| 01.02.24 | ABB Kaufen | DZ BANK | |
| 01.02.24 | Roche Neutral | UBS AG | |
| 01.02.24 | ABB Sector Perform | RBC Capital Markets | |
| 01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | ABB Market-Perform | Bernstein Research | |
| 01.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 01.02.24 | ABB Neutral | UBS AG | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.01.24 | Roche Neutral | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | Roche Sell | Deutsche Bank AG | |
| 30.01.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 29.01.24 | Holcim Kaufen | DZ BANK | |
| 29.01.24 | Givaudan Underweight | Barclays Capital | |
| 26.01.24 | Givaudan Hold | Deutsche Bank AG | |
| 26.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 26.01.24 | Swiss Re Equal Weight | Barclays Capital | |
| 26.01.24 | Givaudan Sell | UBS AG | |
| 26.01.24 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 25.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 25.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 25.01.24 | Givaudan Sell | UBS AG | |
| 24.01.24 | Swiss Re Sector Perform | RBC Capital Markets |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.